Overview
Dominik Berzaczy practices in Vienna, Austria. Mr. Berzaczy is rated as an Advanced expert by MediFind in the treatment of Mesenchymoma. His top areas of expertise are Mesenchymoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Neurofibromatosis Type 1 (NF1).
His clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Mesenchymoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- MesenchymomaMr. Berzaczy isAdvanced. Learn about Mesenchymoma.
- Experienced
- B-Cell LymphomaMr. Berzaczy isExperienced. Learn about B-Cell Lymphoma.
- Colorectal PolypsMr. Berzaczy isExperienced. Learn about Colorectal Polyps.
- Follicular LymphomaMr. Berzaczy isExperienced. Learn about Follicular Lymphoma.
- NeurofibromatosisMr. Berzaczy isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Mr. Berzaczy isExperienced. Learn about Neurofibromatosis Type 1 (NF1).
- Non-Hodgkin LymphomaMr. Berzaczy isExperienced. Learn about Non-Hodgkin Lymphoma.